November 5, 2015
The RBM Initiative Presents New Risk Indicator Library
We have a new Risk Indicator Library from our Risk Based Monitoring Initiative. Check it out!
Explore
News
November 1, 2015
International Clinical Trials: Joint Ventures
Explore
October 26, 2015
Merck’s Deborah Driscoll on TransCelerate’s QMS Initiative
Read this recent Q&A with our Lead of the QMS Initiative.
Explore
October 6, 2015
Applied Clinical Trials: Merck’s Deborah Driscoll on TransCelerate’s QMS Initiative
Explore
September 1, 2015
European Pharmaceutical Contractor: Digesting Data
Explore
August 5, 2015
Applied Clinical Trials: TransCelerate’s Data Transparency Initiative
Explore
July 31, 2015
Health IT Security: How Does Data De-Identification Affect Clinical Research?
Explore
July 30, 2015
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia
The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path), and TransCelerate BioPharma Inc. announce that Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia have been published for use and accessible on the CDISC website.
Explore
June 2, 2015
Authors Representing TransCelerate BioPharma Inc. Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting
A group of nine authors involved with TransCelerate BioPharma Inc. were honored with a Global Inspire Award at DIA’s 2015 Annual Meeting. The recipients of the Author(s) of the Year Award published “Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma’s Approach, Part 1,” in DIA’s official, scientific, peer-reviewed journal, Therapeutic Innovation &…
Explore
May 5, 2015
Applied Clinical Trials: TransCelerate’s Placebo and SOC Data Sharing Initiative
Explore